Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 patients. With severe shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that Continue Reading